期刊文献+

雷公藤内酯酮脂质体的体外释放特性及体外抗肿瘤活性 被引量:1

In vitro Release Characteristics and in vitro Antitumor Activity of Triptonide Liposomes
下载PDF
导出
摘要 目的考察雷公藤内酯酮(Triptonide,TPN)脂质体的体外释放特性及体外抗肿瘤活性。方法反渗透法考察脂质体的体外释放行为;MTT法测定其在体外对人结肠癌细胞SW620和人白血病细胞K562的抗肿瘤活性。结果TPN脂质体在pH 6.8的缓冲环境中的释放符合一级动力学方程,对SW620和K562细胞48 h的半数抑制浓度显著低于TPN溶液。结论TPN脂质体在体外具有缓释特性,能增强TPN的体外抗肿瘤活性,有望开发为临床药用新剂型。 OBJECTIVE To investigate the in vitro release characteristics and anti-tumor activity of triptonide(Triptonide,TPN)liposomes.METHODS Thereverse dialysis method was used to investigate the in vitro release behavior of TPN liposomes.The MTT method was used to detect its anti-tumor activity of human colon cancer cells SW620 and human leukemia cells K562 in vitro.RESULTS The release of TPN liposomes conformed to the first-order kinetic equation in a buffer environment of pH 6.8.The half inhibitory concentration of TPN liposomes in 48 h for SW620 and K562 cells was significantly lower than that of TPN solution.CONCLUSION TPN liposomes have sustained release properties in vitro,the antitumor activity of TPN could be enhanced by TPN liposomes in vitro.The TPN liposomes expected to be developed as a new dosage form for clinical medicine.
作者 戴雅彬 黄慧 张月芬 郭丹 DAI Ya-bin;HUANG Hui;ZHANG Yue-fen;GUO Dan(Science and Technology Service Center,Fujian Health College,Fuzhou 350101,China)
出处 《海峡药学》 2021年第8期14-17,共4页 Strait Pharmaceutical Journal
基金 福建省中青年教师教育科研项目(JZ180547) 福建卫生职业技术学院校级科研项目(2019-1-07)。
关键词 雷公藤内酯酮 脂质体 体外释放 抗肿瘤 Triptonide Liposomes In vitro release Anti-tumor
  • 相关文献

参考文献7

二级参考文献61

  • 1张馨欣,操洪欣,甘勇,朱春柳,潘卫三.羟基喜树碱纳米脂质载体的制备及体外释放[J].中国医药工业杂志,2006,37(12):820-823. 被引量:11
  • 2李娟,张锦琳.褪黑素固体脂质纳米粒的制备及理化性质[J].中国医药工业杂志,2007,38(4):277-281. 被引量:4
  • 3周民强.数学手册[M].北京:工人出版社,1987.690-4. 被引量:2
  • 4Gibaldi M, Perrier D.Pharmacokinetics (2 nd)[M].New York: Marcel Dekker, 1982:188-95. 被引量:1
  • 5Silber M, Bialer M,Yacobi A. Pharmacokinetic/pharmacodynamic basis of controlled drug delivery[M]. In: Joseph RR, Vincent HL eds.Controlled drug delivery,fundamentals and applications,New York: Marcel Dekker,1987: 213-52. 被引量:1
  • 6Rhodes CT. Drug delivery systems: Effects of phamacokinetics on design, evaluation, and production[M]. In:Peter GW, Francis LST eds. Phramacokinetics: regulatory, industrial, academic perspectives,New York: Marcel Dekker,1995:39-58. 被引量:1
  • 7Zhang JW, Zhong DF, Wang CF. A novel method for evaluating in vivo drug release kinetics based on zero-order release pharmacokinetics and dose division[J].S T P Pharma Sciences,2002,12(3): 177-80. 被引量:1
  • 8国家药典委员会.中华人民共和国药典[S].北京:化学工业出版社,2000.附录:63,64. 被引量:127
  • 9RowlandM TozerTN著 彭彬译.临床药动学[M].长沙:湖南科学技术出版社,1999.72-90. 被引量:2
  • 10Mtiller R H, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug dclivery-a review of the state of art [ J ]. Eur J Pharm Biopharm, 2000(50) :161. 被引量:1

共引文献49

同被引文献12

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部